A joint VeraChem, Iowa State University, and University of Colorado Denver study applying QM-VM2 to the calculation of host-guest binding free energies published in the Journal of Chemical Physics.

QM-VM2, which efficiently combines statistical mechanics with quantum mechanical (QM) energy potentials in order to calculate noncovalent binding free energies of host–guest systems, is presented. QM-VM2 efficiently couples the use of semi-empirical QM (SEQM) energies and geometry optimizations with an underlying molecular mechanics (MM) based conformational search, to find low...

VeraChem’s small molecule tools now available on linux desktop

VeraChem has released a linux version of their freely available small molecule tools. The tools are distributed as a bundle of stand-alone executable programs, which do not require any installation. Please see any of the product pages for download instructions.

VeraChem VM2 sample installation with examples now available on Amazon AWS.

VeraChem LLC is pleased to announce the availability of our VM2 software package and related tutorials pre-installed in an Amazon Machine Image on AWS. This AMI is a default install and configuration of the VM2 package and will be particularly useful as an example for those wishing to install the...

VM2 Now Available On AMD Processors

VeraChem LLC is pleased to announce that we now support our VM2 application on AMD processors. We have an AMD optimized package available for download, please just specify the AMD version in your request.

VeraChem is pleased to announce the release of version 2.8 of its binding free energy software package VM2

‎Release of VM2 version 2.8 includes improved multi-GPU support, CloudVM2 support of Google Cloud Platform in addition to AWS, new algorithms for VM2 free energy calculations for ligands with unknown pose, fast-VM2 (30 minute free energies) for ligand series where a scaffold pose is known. Request a license for VM2...

VeraChem’s newly developed CloudVM2 capability applied in early stage R&D efforts

VeraChem has developed a capability to run its protein-ligand binding free energy software package on the Amazon Web Services cloud environment. This CloudVM2 package enables calculation of protein-ligand binding affinities for hundreds of ligands per day, and was recently applied in early stage R&D efforts by Sarfez Pharmaceuticals Inc.

Pfizer now using VeraChem’s multi-GPU enabled version of its VM2 protein-ligand binding free energy software package

VeraChem’s VM2 package has been ported for running on multiple GPUs using a hybrid MPI+CUDA approach. This highly accelerated version of VM2 is now in use by computational chemists at Pfizer.

All software free for academic institutions

All software free for academic institutions

VeraChem makes fully functional versions of all software free for academic institutions.